Evidence map›Paper›PMID 28699018›Full record

ArticleAIDS and behavior2018

Polydrug Use and Heterogeneity in HIV Risk Among People Who Inject Drugs in Estonia and Russia: A Latent Class Analysis.

Isabel Tavitian-Exley, Marie-Claude Boily, Robert Heimer, Anneli Uusküla, Olga Levina, Mathieu Maheu-Giroux

Open access · hybridAbstract read
In one paragraph

Article in AIDS and behavior, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Observational
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 4 countries.

Isabel Tavitian-ExleyDepartment of Infectious Disease Epidemiology, Imperial College London, Norfolk place, London, W21PG, UK. Tavitianexley@gmail.com.
Marie-Claude BoilyDepartment of Infectious Disease Epidemiology, Imperial College London, Norfolk place, London, W21PG, UK. mc.boily@imperial.ac.uk.
Robert HeimerEpidemiology of Microbial Diseases, School of Public Health, Yale University, New Haven, USA.
Anneli UuskülaFaculty of Medicine, University of Tartu, Tartu, Estonia.
Olga LevinaNGO Stellit, St Petersburg, Russian Federation.
Mathieu Maheu-GirouxDepartment of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, Canada.
Imperial College London · GBMcGill University · CAUniversity of Tartu · EEYale University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
NCATS NIH HHS UL1 TR001863
6 · The paper itself

Abstract

Non-medical drug injection is a major risk factor for HIV infection in Russia and Estonia. Multiple drug use (polydrug) has further been associated with increased harms. We compared HIV, injecting and sexual risk associated with polydrug use among people who injected drugs (PWID) in 2012-2013 in Kohtla-Järve (Estonia, n = 591) and St Petersburg (Russia, n = 811). Using latent class analysis, we identified five (poly)drug classes, the largest consisting of single-drug injectors among whom an opioid was the sole drug injected (56% of PWID). The four remaining polydrug classes included polydrug-polyroute injectors who injected and used opiates and stimulants (9%), opiate-stimulant poly-injectors who injected amphetamine-type-stimulants with a primary opiate (7%) and opiate-opioid poly-injectors who injected opioids and opiates (16%). Non-injection stimulant co-users were injectors who also used non-injection stimulants (12%). In multivariable multinomial regressions, all four polydrug classes were associated with greater injection risks than single-drug injection, while opiate-stimulant and opiate-opioid poly-injection were also associated with having multiple sex partners. Riskier behaviours among polydrug-injectors suggest increased potential for transmission of blood-borne and sexually-transmitted infections. In addition to needles/syringes provision, services tailored to PWID drug and risk profiles, could consider drug-appropriate treatment and sexual risk reduction strategies to curb HIV transmission.

Indexed as

Sexual PartnersAdultCentral Nervous System StimulantsDrug UsersEstoniaFemaleHIV InfectionsHumansLatent Class AnalysisMaleNeedle SharingRisk FactorsRisk-TakingRussiaSexual BehaviorSubstance Abuse, IntravenousCentral Nervous System StimulantsAmphetaminesEastern EuropeHeroin/opioidHIVLatent class analysisPeople who inject drugsPolydrug useRisk behaviours

Identifiers

PMID28699018
PMCPMC5878835
OpenAlexW2735772421

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.